Late acute graft-versus-host disease (Q95903): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Doença do enxerto-versus-hospedeiro (GVHD) aguda presente por mais de 100 dias após o transplante. As manifestações clínicas da GVHD aguda geralmente podem ser prontamente distinguidas daquelas da GVHD crônica. A GVHD aguda tardia pode ser devida ao início tardio da doença, à persistência de sintomas por mais 100 dias ou à reativação, frequentemente após descontinuação da terapia imunossupressora. A abordagem e o prognóstico são diferentes dos da GVHD crônica. | |||
| description / en | description / en | ||
Acute graft-versus-host disease (GVHD) present more than 100 days after engraftment. The clinical features of acute graft-versus-host disease can normally be readily distinguished from those of chronic GVHD. Late acute GVHD may be due to late onset, persistence beyond 100 days or reactivation, often after discontinuation of immunosuppressive therapy. Its management and prognosis are different from chronic GVHD. | |||
Revision as of 11:43, 16 August 2026
Acute graft-versus-host disease (GVHD) present more than 100 days after engraftment. The clinical features of acute graft-versus-host disease can normally be readily distinguished from those of chronic GVHD. Late acute GVHD may be due to late onset, persistence beyond 100 days or reactivation, often after discontinuation of immunosuppressive therapy. Its management and prognosis are different from chronic GVHD.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_173108052 |
||
| English | Late acute graft-versus-host disease |
Acute graft-versus-host disease (GVHD) present more than 100 days after engraftment. The clinical features of acute graft-versus-host disease can normally be readily distinguished from those of chronic GVHD. Late acute GVHD may be due to late onset, persistence beyond 100 days or reactivation, often after discontinuation of immunosuppressive therapy. Its management and prognosis are different from chronic GVHD. |
